date,title,source
Oct-19-18,Innovate Biopharmaceuticals adds $5.2M to its coffers,American City Business Journals
Oct-29-18,Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on reducing Intestinal Permeability in a NASH Preclinical Study,GlobeNewswire
Oct-31-18,Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-05-18,"Innovate Biopharmaceuticals Announces Presentation at the BIO-Europe Conference, Copenhagen 2018 - 24th Annual Partnering Conference",GlobeNewswire
Nov-12-18,Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary Leaky Gut Assay Demonstrating Reduced Intestinal Permeability with Larazotide Acetate Treatment in a NASH Preclinical Study,GlobeNewswire
Nov-13-18,Innovate Biopharmaceuticals Reports Third Quarter 2018 Earnings and Key Corporate Highlights,GlobeNewswire
Nov-26-18,"Innovate Biopharmaceuticals Strengthens Clinical Development with the Addition of Patrick H. Griffin, M.D., F.A.C.P.",GlobeNewswire
Dec-04-18,"Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018",GlobeNewswire
Dec-11-18,Today's Research Reports on Trending Tickers: Teva Pharmaceutical and Innovate Biopharmaceuticals,ACCESSWIRE
Dec-14-18,Healthcare Stocks That Could Weather the Market Volatility,ACCESSWIRE
Dec-17-18,Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019,GlobeNewswire
Dec-17-18,Today's Research Reports on Trending Tickers: Innovate Biopharmaceuticals and Tenet Healthcare,ACCESSWIRE
Dec-25-18,"Could Innovate Biopharmaceuticals, Inc.s (NASDAQ:INNT) Investor Composition Influence The Stock Price?",Simply Wall St.
Feb-07-19,Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference,GlobeNewswire
Feb-22-19,Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer,GlobeNewswire
Feb-25-19,Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference,GlobeNewswire
Feb-26-19,Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates,GlobeNewswire
Mar-01-19,"Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019",GlobeNewswire
